According to FutureWise analysis, the market for capsule endoscopy in 2025 is US$ 0.57 billion, and is expected to reach US$ 1.1 billion by 2033 at a CAGR of 8.6%. The rising incidence of gastrointestinal disorders, such as Crohn's disease, obscure gastrointestinal bleeding, and colorectal cancer, is a significant factor contributing to the growing popularity of capsule endoscopy. This technology is becoming more widely adopted in healthcare settings around the world due to its minimally invasive approach, improved imaging capabilities, and patient-friendly diagnostic features.

Capsule endoscopy is a process used to capture images of the digestive tract using a tiny, wireless camera. The patient swallows a small capsule that contains the endoscopy camera, which then travels through the digestive system. While moving through the tract, the camera takes numerous pictures that are transmitted to a recorder mounted on a waist belt. This method allows doctors to examine the small intestine without needing surgical procedures, making it more efficient than traditional endoscopy, which uses a wired camera. Capsule endoscopy is now approved for colon screenings to detect polyps. Technological advancements are promoting the regular use of capsule endoscopy in colon screening.

The growing emphasis on minimally invasive techniques for primary diagnosis in healthcare systems has led to significant market growth. This has created substantial opportunities for manufacturers and prompted the inclusion of capsule endoscopy in national and international guidelines. It represents a major technological innovation in recent years, driven by the high demand for primary diagnosis and management of bowel disorders. This progress is supported by extensive research efforts from manufacturers. Furthermore, rapid advancements in technology have resulted in a paradigm shift, broadening the range of clinical applications for capsule endoscopy. It has become an invaluable tool in clinical practice and outperforms other investigative methods. Additionally, the increasing prevalence of gastric disorders has contributed to its growing popularity during the forecast period.

Artificial Intelligence (AI) Integration: AI-assisted capsule endoscopy is revolutionizing gastrointestinal diagnostics by improving lesion detection and enhancing reading efficiency.

Robotic and Magnetic Capsule Endoscopy: Innovations in magnetic capsule endoscopy enhance efficiency, accuracy, and navigation within the gastrointestinal tract. Robotic capsule endoscopy, which employs magnetic fields, is vital for detecting various conditions such as tumors, gastrointestinal bleeding, Crohn’s disease, and celiac disease.

FutureWise Market Research has published a report that provides an insightful analysis of Capsule Endoscopy Market trends that are affecting the overall market growth.



Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=185&type=requestsample

Capsule Endoscopy Market Segmentation:

By Component

  • Capsule Endoscope
  • Capsule Endoscopy Data Recorder
  • Capsule Endoscopy Workstation

By Endoscope Type

  • Capsule Cystoscopies
  • Capsule Neuro-Endoscopes

By Product

  • Small Bowel Capsule
  • Esophageal Capsule
  • Colon Capsule

By Application

  • Obscure Gastrointestinal Bleeding (OGIB)
  • Crohn’s Disease
  • Small Intestine Tumor

By End User

  • Hospitals
  • Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape in Capsule Endoscopy Market:

  • Olympus Corporation
  • RF Co. Ltd.
  • IntroMedic Co., Ltd.
  • AccuRead Endoscopy Inc.
  • Boston Scientific Corporation
  • Medtronic Plc
  • CapsoVision, Inc.
  • Northside Gastroenterology Endoscopy Center, LLC
  • Chongqing Jinshan Science and Technology Co.
  • Interscope Inc.
  • Given Imaging Ltd.

Recent developments by key players in Capsule Endoscopy Market:

Medtronic 

In May 2024, Medtronic received FDA clearance for its next-generation PillCam™ Genius SB capsule system, which offers improved imaging clarity and a longer battery life. The first patient procedure was successfully performed in December 2024 in collaboration with the University of Miami Health System.

CapsoVision

In January 2025, CapsoVision obtained U.S. FDA clearance for CapsoCam Plus, allowing its use in pediatric patients aged 2 and older—marking its first pediatric indication and opening a new segment in capsule endoscopy diagnostics.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=185&license=multi

**Objectives of this Study: **

  1. To provide a comprehensive analysis of the Capsule Endoscopy Market By Component, By Endoscope Type, By Product, By Application, By End User and By Region.
  2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
  3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
  4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
  • The customization services offered are free of charge with the purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com